Skip to content
800 CELIS line no background
  • Home
  • Blog
    • All Posts
    • Series: Inv-Sec-Arb
    • Series: CELIS–L&G
    • Series: Rev-Screen-Reg
  • Engage
    • Overview
    • Your Options
    • Current Sponsors
    • Alumni Partners
  • Events
    • CFIS 26 Brussels
    • Leaders Tokyo 26
    • Salon
    • Thought Leaders
      • About
      • 7 – Santiago Edition
      • 6 – London Edition
      • 5 – Bucharest Edition
      • 4 – Paris Edition
      • 3 – Brussels Edition
      • 2 – Stockholm Edition
      • 1 – Berlin Edition
    • Past events
      • CFIS 25 – Berlin
      • CFIS 24 – Paris
      • CFIS 23 – Prague
      • CFIS 22 – Uppsala
      • CELIS 21
      • CELIS 20
      • CELIS 19
      • Leaders Singapore 26
      • Leaders DC 26
      • Leaders DC 25
      • Leaders DC 24
      • CELIS × A&P – London 26
      • BDI–CELIS German Chapter 25
      • BDI-CELIS German Chapter 24
      • CELIS German Chapter Roundtable
      • CELIS NOW KICK-OFF 23
      • 30minutes/CELIS Briefings
      • Partner Events
  • Advisory
  • Resources
    • Blog
    • Country Reports
    • Board of Country Reporters
    • Non-Papers
  • Centres
    • Investment Security in Investment Arbitration
  • About
    • Mission
    • Team
    • Trustees
    • Advisory Fellows
    • Contact

Boom times for pharma M&A – European Pharmaceutical Review

18. February 2021

Boom times for pharma M&A  European Pharmaceutical Review

  • tweet 
  • share  
  • share 
  • share 
  • share 
Print Friendly, PDF & Email
Posted in CELIS-NEWS

Recent Posts

  • Foreign Direct Investment Regimes Laws and Regulations Report 2026 Spain – ICLG
  • Ukraine will screen foreign investors before entering strategic sectors: which areas are under control – Судово-юридична газета
  • Filip & Company: Investment screening in Romania matures. Impact of new amendments on transactions – Business Review
  • How Should a Small State Screen Foreign Investment Without Scaring It Away?
  • Foreign direct investment reviews 2026: Austria – White & Case LLP

Categories

  • CELIS Advisory Publications
  • CELIS Institute
  • CELIS Non-Papers
  • CELIS-Blog
  • CELIS-CONTENT
  • CELIS-Country-Reports
  • CELIS-EVENT
  • CELIS-EVENT-30minutes
  • CELIS-L&G blog
  • CELIS-NEWS
  • CELIS-PARTNER-EVENT
  • CELIS-PEOPLE
  • CFIS 2022
  • CFIS 24
  • Chair CELIS 2019
  • Chair CELIS 2020
  • Commentator CELIS 2019
  • Conference Package
  • Contributors CELIS 2019
  • Contributors CELIS 2020
  • Hosts CELIS 2019
  • Hosts CELIS 2020
  • Keynote CELIS 2019
  • Posts CELIS 2019
  • Posts CELIS 2020
  • Speaker CELIS 2019
  • Speaker CELIS 2020
  • Imprint
  • Data Protection
  • General Terms and Conditions
  • Vertrag widerrufen
© CELIS / DESIGN + KONZEPT © 2020 WWW.SMG-WEBDESIGN.DE

Sign up for our CELIS Institute Newsletter

Stay up-to-date on investment screening and economic security issues.
!
!
!

Please take a moment to read the linked General Terms and Conditions as well as the Data Protection Policy (esp. point "7. Newsletter") carefully. See here for our Data Protection Policy and for our General Terms and Conditions.

You will receive an email to confirm your subscription in a moment. Sometimes the email ends up in the spam folder, please have a look there as well.

Terms and Conditions checkbox is required.
Subscribe
Something went wrong. Please check your entries and try again.

Scroll To Top